Simulations Plus Inc.

Simulations Plus, Inc. delivers AI‑powered drug discovery and development software—GastroPlus, DILIsym, ADMET Predictor, and Monolix Suite—serving pharma, biotech, agrochemicals, and regulatory markets worldwide, driving efficiencies in PK/PD modeling and regulatory submissions.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Technology, Information and Media
Industry: Software Development

Employees: 212
HQ: Research Triangle Park

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
SLP	Simulations Plus Inc. Cap: 0.4B	EQUITY	NMS	USD	US8292141053	Active	📈